Note: If you use other eye drops in addition to Restasis, you can probably still use those drops while you’re using Restasis. But make sure to check with your doctor about which eye drops are safe to ...

Michelle Hessen, OD, spoke about the results of a new study evaluating the efficacy of cyclosporine ophthalmic solution 0.09% in patients with dry eye. This was a phase 4, single-arm, multicenter ...

If you have dry eye, you know how uncomfortable it can be. Dry eye disease happens when your eyes do not make enough quality tears or when your tears dry out too quickly. This can lead to eye ...

NASHVILLE, Tenn.--(BUSINESS WIRE)--Harrow (Nasdaq: HROW), a leading U.S. eyecare pharmaceutical company, today announced that VEVYE® (cyclosporine ophthalmic solution) 0.1%, a patented, non‑preserved, ...

HEIDELBERG, Germany and CAMBRIDGE, MA, USA--(BUSINESS WIRE)--Novaliq GmbH, a biopharmaceutical company focusing on first- and best-in-class ocular therapeutics, today announced that the U.S. Food and ...

VEVYE® is the First and Only Cyclosporine-Based Product Indicated for the Treatment of Both Signs and Symptoms of Dry Eye Disease with Efficacy Demonstrated After Four Weeks VEVYE® is the Only ...

Please provide your email address to receive an email when new articles are posted on . A water-free cyclosporine 0.1% solution showed efficacy in improving dry eye signs and symptoms. Tolerability, ...

BRIDGEWATER, N.J., Dec. 01, 2025 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (AMRX) today announced the U.S. Food and Drug Administration (FDA) has approved the Company’s cyclosporine ophthalmic ...

Presentation at the American Academy of Optometry (AAOPT) 2023 showed significant improvements with CEQUA ® for topical ophthalmic use in both corneal fluorescein staining (CFS) and symptom ...

Please provide your email address to receive an email when new articles are posted on . The cyclosporine group experienced greater improvement in total fluorescein staining compared with the vehicle ...

Vernal keratoconjunctivitis is a rare allergic eye disease that affects the pediatric population and results in severe inflammation of the surface of the eye. The Food and Drug Administration (FDA) ...

NASHVILLE, Tenn., May 17, 2021 (GLOBE NEWSWIRE) -- ImprimisRx, the nation’s leading ophthalmic-focused outsourcing facility and pharmaceutical compounding business and a wholly owned subsidiary of ...